ProteoGenix double ses installations de R&D pour ouvrir la voie à une utilisation animale minimale dans le développement de produits biologiques
ProteoGenix Doubles R&D Facilities to Pave the Way for Minimal Animal Use in Biologics Development New facilities support the fast growth and expansion of the phage display, antibody development, and bioproduction platforms Schiltigheim, France: ProteoGenix, a contract research organization specializing in biologics discovery and bioproduction, is pleased to announce the expansion [...]